PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology

被引：0
作者：
Andreas von Knethen
Bernhard Brüne
机构：
[1] Goethe-University Frankfurt,Institute of Biochemistry I
来源：
Signal Transduction and Targeted Therapy | / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 6 条
[1]  
Yao H(2019)Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours Nat. Biomed. Eng. 3 306-317
[2]  
Friedman CF(2017)Atypical autoimmune adverse effects with checkpoint blockade therapies Ann. Oncol. 28 206-207
[3]  
Snyder A(2018)The intracellular signalosome of PD-L1 in cancer cells Signal Transduct Target Ther. 3 26-396
[4]  
Escors D(2018)Regulation of PD-L1: emerging routes for targeting tumor immune evasion Front Pharmacol. 9 536-undefined
[5]  
Wang Y(2016)Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling Mol. Cell 62 385-undefined
[6]  
Runkle KB(undefined)undefined undefined undefined undefined-undefined
1